Ventracor (VCR)

Stock Code


Stock Exchange


Ventracor (VCR) is an international medical device company focused on the development of an implantable blood pump, the VentrAssist left ventricular assist device (LVAD). LVAD is designed as a substitute to heart transplantation for people in end-stage heart failure. The Company is principally engaged in the research, development, manufacture, clinical trials and marketing of the VentrAssist LVAD and related technologies. Ventracor listed on the Australian Stock Exchange on August 17, 1993.

Ventracor (VCR) Stock Recommendation

ABN Amro have rated the Ventracor (VCR) stock as a Buy with their share price target at $1.13, up 4 cents while valuation is down 4 cents to $1.62. . The analyst has noted that while the company has begun to generate revenue from sales of its VentrAssist device, there may be delats in the approval process. ABN Amro have increased forecast loss for FY07 from $17.7 milltion to $21.3 million and in FY08 from $5.7 million to $6.6 million.

Syndicate content

Recommended Websites